Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan W Hampson

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Communicable Diseases Intelligence Quarterly Report|October 29, 2004
Surveillance for neuraminidase inhibitor resistance in human influenza viruses from AustraliaAeron C Hurt, Ian G Barr, Christopher J Durrant, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2006
Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patientAeron C Hurt, Pina Iannello, Kim Jachno, et al.
The Medical Journal of Australia|June 18, 2004
Influenza outbreaks in aged-care facilities: staff vaccination and the emerging use of antiviral therapyRebecca J Guy, Richard Di Natale, Heath A Kelly, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their useArnold S Monto, Jennifer L McKimm-Breschkin, Catherine Macken, et al.
Drugs in Context|January 18, 2021
Key policy and programmatic factors to improve influenza vaccination rates based on the experience from four high-performing countriesGeorge Kassianos, Ashis Banerjee, Florence Baron-Papillon, et al.
Vaccine|February 21, 2009
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza virusesColin A Russell, Terry C Jones, Ian G Barr, et al.
Science (New York, N.Y.)|April 19, 2008
The global circulation of seasonal influenza A (H3N2) virusesColin A Russell, Terry C Jones, Ian G Barr, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Communicable Diseases Intelligence Quarterly Report|October 29, 2004
Surveillance for neuraminidase inhibitor resistance in human influenza viruses from AustraliaAeron C Hurt, Ian G Barr, Christopher J Durrant, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2006
Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patientAeron C Hurt, Pina Iannello, Kim Jachno, et al.
The Medical Journal of Australia|June 18, 2004
Influenza outbreaks in aged-care facilities: staff vaccination and the emerging use of antiviral therapyRebecca J Guy, Richard Di Natale, Heath A Kelly, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their useArnold S Monto, Jennifer L McKimm-Breschkin, Catherine Macken, et al.
Drugs in Context|January 18, 2021
Key policy and programmatic factors to improve influenza vaccination rates based on the experience from four high-performing countriesGeorge Kassianos, Ashis Banerjee, Florence Baron-Papillon, et al.
Vaccine|February 21, 2009
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza virusesColin A Russell, Terry C Jones, Ian G Barr, et al.
Science (New York, N.Y.)|April 19, 2008
The global circulation of seasonal influenza A (H3N2) virusesColin A Russell, Terry C Jones, Ian G Barr, et al.
Pageof 3